** Sartorius' SATG.DE stock rises 9% in early Frankfurt trade after the pharmaceutical equipment supplier posted Q1 results above market expectations
** Underlying EBITDA came in at 263 million euros ($298.98 million), above analysts' estimates of 234.4 million euros according to a consensus compiled by Vara Research
** The group's book-to-bill ratio came in well above 1, it added, which should reassure the market of a continued recovery, analysts at Jefferies say
** Given the strong results "we expect the shares to outperform by at least 10% today,", analysts at J.P.Morgan say
($1 = 0.8797 euros)
(Reporting by Isabel Demetz)
((Isabel.demetz@thomsonreuters.com))